{"id":28838,"date":"2023-12-20T14:22:20","date_gmt":"2023-12-20T14:22:20","guid":{"rendered":"https:\/\/breastcancer.knowledgehub.wiley.com\/artikel\/klinisches-potenzial-von-cdk4-6-inhibitoren-bei-brustkrebsdr-rachel-wuerstlein\/"},"modified":"2024-03-22T16:22:02","modified_gmt":"2024-03-22T16:22:02","slug":"fallstudie-rachel-wuerstlein","status":"publish","type":"post","link":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/","title":{"rendered":"Klinisches Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs<br><small>Dr. Rachel W\u00fcrstlein<\/small>"},"content":{"rendered":"\n<p>In dieser Fallstudie diskutiert Dr. Rachel Wu\u0308rstlein das klinische Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs.<\/p>\n  <style>\n  video-js.video-js.vjs-fluid:not(.vjs-audio-only-mode) {\n    padding-top: 56.25%;\n  }\n  <\/style><video-js data-account=\"656326989001\" data-player=\"OQw83zhdgh\" data-embed=\"default\" controls=\"\" data-video-id=\"6343603168112\" data-playlist-id=\"\" data-application-id=\"\"><\/video-js>\n\tMachen Sie das Quiz zur Fallstudie:<br>\n<script>\n                            if (window.qmn_quiz_data === undefined) {\n                                    window.qmn_quiz_data = new Object();\n                            }\n                    <\/script><script>window.qmn_quiz_data[\"3\"] = {\"quiz_id\":\"3\",\"quiz_name\":\"Rachel W\\u00fcrstlein - CDK4\\\/6 inhibitor in invasive disease-free survival of breast cancer patients\",\"disable_answer\":0,\"ajax_show_correct\":0,\"progress_bar\":\"0\",\"contact_info_location\":\"0\",\"qpages\":{\"1\":{\"id\":\"1\",\"quizID\":\"3\",\"pagekey\":\"rTAy7O4e\",\"hide_prevbtn\":\"0\"}},\"skip_validation_time_expire\":0,\"timer_limit_val\":\"0\",\"disable_scroll_next_previous_click\":0,\"disable_scroll_on_result\":0,\"disable_first_page\":\"0\",\"enable_result_after_timer_end\":0,\"enable_quick_result_mc\":0,\"end_quiz_if_wrong\":0,\"form_disable_autofill\":0,\"disable_mathjax\":0,\"enable_quick_correct_answer_info\":0,\"quick_result_correct_answer_text\":\"Correct! You have selected correct answer.\",\"quick_result_wrong_answer_text\":\"Wrong! You have selected wrong answer.\",\"quiz_processing_message\":\"\",\"quiz_limit_choice\":\"Limit of choice is reached.\",\"not_allow_after_expired_time\":0,\"scheduled_time_end\":false,\"prevent_reload\":0,\"limit_email_based_submission\":0,\"total_user_tries\":0,\"is_logged_in\":false,\"error_messages\":{\"email_error_text\":\"Not a valid e-mail address!\",\"number_error_text\":\"This field must be a number!\",\"incorrect_error_text\":\"The entered text is not correct!\",\"empty_error_text\":\"Please complete all required fields!\",\"url_error_text\":\"The entered URL is not valid!\",\"minlength_error_text\":\"Required atleast %minlength% characters.\",\"maxlength_error_text\":\"Maximum %maxlength% characters allowed.\",\"recaptcha_error_text\":\"ReCaptcha is missing\"},\"first_page\":false,\"questions_settings\":[]}\n                    <\/script>\t\t<div class='qsm-quiz-container qsm-quiz-container-3 qmn_quiz_container mlw_qmn_quiz  quiz_theme_default  '>\n\t\t\t\t\t\t\t\t<form name=\"quizForm3\" id=\"quizForm3\" action=\"\/de\/wp-json\/wp\/v2\/posts\/28838\" method=\"POST\" class=\"qsm-quiz-form qmn_quiz_form mlw_quiz_form\" novalidate enctype=\"multipart\/form-data\">\n\t\t\t\t<input type=\"hidden\" name=\"qsm_hidden_questions\" id=\"qsm_hidden_questions\" value=\"\">\n\t\t\t\t<input type=\"hidden\" name=\"qsm_nonce\" id=\"qsm_nonce_3\" value=\"191af87cb7\">\n\t\t\t\t<input type=\"hidden\" name=\"qsm_unique_key\" id=\"qsm_unique_key_3\" value=\"6a09e76563a25\">\n\t\t\t\t<div id=\"mlw_error_message\" class=\"qsm-error-message qmn_error_message_section\"><\/div>\n\t\t\t\t<span id=\"mlw_top_of_quiz\"><\/span>\n\t\t\t\t\t\t\t<section class=\"qsm-page \">\n\t\t\t\t\t\t\t\t<div class=\"quiz_section quiz_begin\">\n\t\t\t\t\t\t<div class='qsm-before-message mlw_qmn_message_before'>\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"quiz_section qsm-question-wrapper question-type-0 question-section-id-3 \" data-qid=\"3\">\n\t\t\t\t\t\t<div class='mlw_qmn_new_question'>What is the most common side effects of Abemaciclib? <\/div>\n\t\t\t<div class='mlw_qmn_question  qsm_remove_bold' >\n\t\t<p><\/p>\n\t<\/div>\n\t\t<fieldset>\n\t\t<legend><\/legend>\n\t<div class='qmn_radio_answers '>\n\t\t\t\t\t\t\t\t<div class=\"qmn_mc_answer_wrap  mrq_checkbox_class\" id=\"question3-1 \">\n\t\t\t\t\t\t\t\t\t\t\t<input type='radio' class='qmn_quiz_radio qmn-multiple-choice-input ' name=\"question3\" id=\"question3_1\" value=\"0\" \/>\n\t\t\t\t\t<label class=\"qsm-input-label\" for=\"question3_1\">\n\t\t\t\t\tQT prolongation\t\t\t\t\t<\/label>\n\t\t\t\t\t \t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"qmn_mc_answer_wrap  mrq_checkbox_class\" id=\"question3-2 \">\n\t\t\t\t\t\t\t\t\t\t\t<input type='radio' class='qmn_quiz_radio qmn-multiple-choice-input ' name=\"question3\" id=\"question3_2\" value=\"1\" \/>\n\t\t\t\t\t<label class=\"qsm-input-label\" for=\"question3_2\">\n\t\t\t\t\tFatigue\t\t\t\t\t<\/label>\n\t\t\t\t\t \t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"qmn_mc_answer_wrap  mrq_checkbox_class\" id=\"question3-3 \">\n\t\t\t\t\t\t\t\t\t\t\t<input type='radio' class='qmn_quiz_radio qmn-multiple-choice-input ' name=\"question3\" id=\"question3_3\" value=\"2\" \/>\n\t\t\t\t\t<label class=\"qsm-input-label\" for=\"question3_3\">\n\t\t\t\t\tNeutropenia\t\t\t\t\t<\/label>\n\t\t\t\t\t \t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"qmn_mc_answer_wrap  mrq_checkbox_class\" id=\"question3-4 \">\n\t\t\t\t\t\t\t\t\t\t\t<input type='radio' class='qmn_quiz_radio qmn-multiple-choice-input ' name=\"question3\" id=\"question3_4\" value=\"3\" \/>\n\t\t\t\t\t<label class=\"qsm-input-label\" for=\"question3_4\">\n\t\t\t\t\tDiarrhea\t\t\t\t\t<\/label>\n\t\t\t\t\t \t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"qmn_mc_answer_wrap  mrq_checkbox_class\" id=\"question3-5 \">\n\t\t\t\t\t\t\t\t\t\t\t<input type='radio' class='qmn_quiz_radio qmn-multiple-choice-input ' name=\"question3\" id=\"question3_5\" value=\"4\" \/>\n\t\t\t\t\t<label class=\"qsm-input-label\" for=\"question3_5\">\n\t\t\t\t\tElevated liver enzymes\t\t\t\t\t<\/label>\n\t\t\t\t\t \t\t\t\t<\/div>\n\t\t\t\t\t \t\t\t<label style=\"display: none !important;\" for=\"question3_none\">None<\/label>\n\t\t\t<input type=\"radio\" style=\"display: none;\" name=\"question3\" id=\"question3_none\" checked=\"checked\" value=\"\" \/>\n\t\t\t\t<\/div>\n\t<\/fieldset>\n\t<input type=\"hidden\" name=\"answer_limit_keys_3\" value=\"\" \/>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/section>\n\t\t\t\t\t<input type=\"hidden\" name=\"qmn_question_list\" value=\"3Q\" \/>\n\t\t\t\t\t\t\t<div id=\"mlw_error_message_bottom\" class=\"qsm-error-message qmn_error_message_section\"><\/div>\n\t\t\t\t\t<input type=\"hidden\" name=\"qmn_all_questions_count\" id=\"qmn_all_questions_count\" value=\"1\" \/>\n\t\t\t\t\t<input type=\"hidden\" name=\"total_questions\" id=\"total_questions\" value=\"1\" \/>\n\t\t\t\t\t<input type=\"hidden\" name=\"timer\" id=\"timer\" value=\"0\" \/>\n\t\t\t\t\t<input type=\"hidden\" name=\"timer_ms\" id=\"timer_ms\" value=\"0\"\/>\n\t\t\t\t\t<input type=\"hidden\" class=\"qmn_quiz_id\" name=\"qmn_quiz_id\" id=\"qmn_quiz_id\" value=\"3\" \/>\n\t\t\t\t\t<input type='hidden' name='complete_quiz' value='confirmation' \/>\n\t\t\t\t\t\t\t\t\t<\/form>\n\t\t\t\t\t\t<\/div>\n\t\t<div style=\"display: none;\" class=\"qsm-popup qsm-popup-slide\" id=\"modal-4\" aria-hidden=\"false\"><div class=\"qsm-popup__overlay\" tabindex=\"-1\" data-micromodal-close=\"\"><div class=\"qsm-popup__container qmn_quiz_container\" role=\"dialog\" aria-modal=\"true\"><div class=\"qsm-popup__content\"><img decoding=\"async\" src=\"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/plugins\/quiz-master-next\/assets\/clock.png\" alt=\"clock.png\"\/><p class=\"qsm-time-up-text\"> Time's up<\/p><\/div><footer class=\"qsm-popup__footer\"><button class=\"qsm-popup-secondary-button qmn_btn\" data-micromodal-close=\"\" aria-label=\"Close this dialog window\" onclick=\"location.reload();\">Cancel<\/button><\/footer><\/div><\/div><\/div>\n\t\t\t\t\t\t\t\t\t\t<a class=\"uabb-ss-grid-button-link\" href=\"https:\/\/www.xing.com\/app\/user?op=share&amp;url=https%3A%2F%2Fbreastcancer.knowledgehub.wiley.com%2Fde%2F%3Fp%3D28838%26fl_builder\" target=\"_blank\" onclick=\"window.open(this.href,'social-share','left=20,top=20,width=500,height=500,toolbar=1,resizable=0');return false;\" rel=\"noopener\">\n\t\t\t\t\t\t\t\tXing\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<a class=\"uabb-ss-grid-button-link\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fbreastcancer.knowledgehub.wiley.com%2Fde%2F%3Fp%3D28838%26fl_builder\" target=\"_blank\" onclick=\"window.open(this.href,'social-share','left=20,top=20,width=500,height=500,toolbar=1,resizable=0');return false;\" rel=\"noopener\">\n\t\t\t\t\t\t\t\tFacebook\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<a class=\"uabb-ss-grid-button-link\" href=\"https:\/\/twitter.com\/share?url=https%3A%2F%2Fbreastcancer.knowledgehub.wiley.com%2Fde%2F%3Fp%3D28838%26fl_builder\" target=\"_blank\" onclick=\"window.open(this.href,'social-share','left=20,top=20,width=500,height=500,toolbar=1,resizable=0');return false;\" rel=\"noopener\">\n\t\t\t\t\t\t\t\tTwitter\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<a class=\"uabb-ss-grid-button-link\" href=\"https:\/\/www.linkedin.com\/shareArticle?url=https%3A%2F%2Fbreastcancer.knowledgehub.wiley.com%2Fde%2F%3Fp%3D28838%26fl_builder\" target=\"_blank\" onclick=\"window.open(this.href,'social-share','left=20,top=20,width=500,height=500,toolbar=1,resizable=0');return false;\" rel=\"noopener\">\n\t\t\t\t\t\t\t\tLinkedin\n\t\t\t\t\t\t\t\t\t\t<\/a>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":10,"featured_media":28833,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[118],"tags":[165],"class_list":["post-28838","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kommentare-fuehrender-experten","tag-fallstudie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Klinisches Potenzial von CDK4\/6-Inhibitoren bei BrustkrebsDr. Rachel W\u00fcrstlein - Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen<\/title>\n<meta name=\"description\" content=\"In dieser Fallstudie diskutiert Dr. Rachel Wu\u0308rstlein das klinische Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Klinisches Potenzial von CDK4\/6-Inhibitoren bei BrustkrebsDr. Rachel W\u00fcrstlein - Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen\" \/>\n<meta property=\"og:description\" content=\"In dieser Fallstudie diskutiert Dr. Rachel Wu\u0308rstlein das klinische Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/\" \/>\n<meta property=\"og:site_name\" content=\"Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-20T14:22:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-22T16:22:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mike Echalaz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mike Echalaz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/\"},\"author\":{\"name\":\"Mike Echalaz\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#\/schema\/person\/f6185d30d46da842fcbb08771556782c\"},\"headline\":\"Klinisches Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs Dr. Rachel W\u00fcrstlein\",\"datePublished\":\"2023-12-20T14:22:20+00:00\",\"dateModified\":\"2024-03-22T16:22:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/\"},\"wordCount\":39,\"publisher\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#organization\"},\"image\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg\",\"keywords\":[\"Fallstudie\"],\"articleSection\":[\"Kommentar f\u00fchrender Experten\"],\"inLanguage\":\"de-DE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/\",\"url\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/\",\"name\":\"Klinisches Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs Dr. Rachel W\u00fcrstlein - Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen\",\"isPartOf\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg\",\"datePublished\":\"2023-12-20T14:22:20+00:00\",\"dateModified\":\"2024-03-22T16:22:02+00:00\",\"description\":\"In dieser Fallstudie diskutiert Dr. Rachel Wu\u0308rstlein das klinische Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs.\",\"breadcrumb\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#primaryimage\",\"url\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg\",\"contentUrl\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg\",\"width\":500,\"height\":281,\"caption\":\"Rachel Wurstlein Case Study\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Klinisches Potenzial von CDK4\/6-Inhibitoren bei BrustkrebsDr. Rachel W\u00fcrstlein\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#website\",\"url\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/\",\"name\":\"Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen\",\"description\":\"Breast Cancer focused knowledge hub of resources, webinars, latest research and clinical updates for health care professionals who are treating patients living with Breast Cancer\",\"publisher\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#organization\",\"name\":\"Wiley\",\"url\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/02\/Wiley_Logo.jpg\",\"contentUrl\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/02\/Wiley_Logo.jpg\",\"width\":696,\"height\":696,\"caption\":\"Wiley\"},\"image\":{\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#\/schema\/person\/f6185d30d46da842fcbb08771556782c\",\"name\":\"Mike Echalaz\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Klinisches Potenzial von CDK4\/6-Inhibitoren bei BrustkrebsDr. Rachel W\u00fcrstlein - Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen","description":"In dieser Fallstudie diskutiert Dr. Rachel Wu\u0308rstlein das klinische Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/","og_locale":"de_DE","og_type":"article","og_title":"Klinisches Potenzial von CDK4\/6-Inhibitoren bei BrustkrebsDr. Rachel W\u00fcrstlein - Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen","og_description":"In dieser Fallstudie diskutiert Dr. Rachel Wu\u0308rstlein das klinische Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs.","og_url":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/","og_site_name":"Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen","article_published_time":"2023-12-20T14:22:20+00:00","article_modified_time":"2024-03-22T16:22:02+00:00","og_image":[{"width":500,"height":281,"url":"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg","type":"image\/jpeg"}],"author":"Mike Echalaz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mike Echalaz","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#article","isPartOf":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/"},"author":{"name":"Mike Echalaz","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#\/schema\/person\/f6185d30d46da842fcbb08771556782c"},"headline":"Klinisches Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs Dr. Rachel W\u00fcrstlein","datePublished":"2023-12-20T14:22:20+00:00","dateModified":"2024-03-22T16:22:02+00:00","mainEntityOfPage":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/"},"wordCount":39,"publisher":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#organization"},"image":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#primaryimage"},"thumbnailUrl":"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg","keywords":["Fallstudie"],"articleSection":["Kommentar f\u00fchrender Experten"],"inLanguage":"de-DE"},{"@type":"WebPage","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/","url":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/","name":"Klinisches Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs Dr. Rachel W\u00fcrstlein - Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen","isPartOf":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#primaryimage"},"image":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#primaryimage"},"thumbnailUrl":"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg","datePublished":"2023-12-20T14:22:20+00:00","dateModified":"2024-03-22T16:22:02+00:00","description":"In dieser Fallstudie diskutiert Dr. Rachel Wu\u0308rstlein das klinische Potenzial von CDK4\/6-Inhibitoren bei Brustkrebs.","breadcrumb":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#primaryimage","url":"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg","contentUrl":"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/12\/Rachel-Wurstlein-Case-Study-FI.jpg","width":500,"height":281,"caption":"Rachel Wurstlein Case Study"},{"@type":"BreadcrumbList","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/kommentare-fuehrender-experten\/fallstudie-rachel-wuerstlein\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/"},{"@type":"ListItem","position":2,"name":"Klinisches Potenzial von CDK4\/6-Inhibitoren bei BrustkrebsDr. Rachel W\u00fcrstlein"}]},{"@type":"WebSite","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#website","url":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/","name":"Bildungsressourcen zum Thema Brustkrebs f\u00fcr medizinische Fachpersonen","description":"Breast Cancer focused knowledge hub of resources, webinars, latest research and clinical updates for health care professionals who are treating patients living with Breast Cancer","publisher":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#organization","name":"Wiley","url":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/02\/Wiley_Logo.jpg","contentUrl":"https:\/\/breastcancer.knowledgehub.wiley.com\/wp-content\/uploads\/2023\/02\/Wiley_Logo.jpg","width":696,"height":696,"caption":"Wiley"},"image":{"@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/#\/schema\/person\/f6185d30d46da842fcbb08771556782c","name":"Mike Echalaz"}]}},"_links":{"self":[{"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/posts\/28838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/comments?post=28838"}],"version-history":[{"count":9,"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/posts\/28838\/revisions"}],"predecessor-version":[{"id":29348,"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/posts\/28838\/revisions\/29348"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/media\/28833"}],"wp:attachment":[{"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/media?parent=28838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/categories?post=28838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breastcancer.knowledgehub.wiley.com\/de\/wp-json\/wp\/v2\/tags?post=28838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}